Pitfalls in the Management of Trophoblastic Disease in Africa
A clinician managing trophoblastic disease in Africa is inevitably faced with a number of fundamental problems. Among these are inadequate data on the magnitude of trophoblastic disease as a public health problem, late diagnosis and therefore advanced nature of the disease, non-availability or restrictive costs of chemotherapeutic agents, difficulties in monitoring patients during chemotherapy, and poor patient compliance, making follow-up of cases difficult.
KeywordsLuteinizing Hormone Luteinizing Hormone Level Hydatidiform Mole Treatment Summary East Central
Unable to display preview. Download preview PDF.
- 2.Makokha, A. E. and Mati, J. K. G., Choriocarcinoma at Kenyatta National Hospital, 1973–79, J. Obstet. Gynae. East Central Afr. 1: 27 (1982).Google Scholar
- 5.Sekadde-Kigondu, C. B., Fongoh, F. B., et al., The use of luteinizing hormone (LH) and beta human chorionic gonadotropin RIA in the diagnosis and treatment of choriocarcinoma at Kenyatta. National Hospital, J. Obstet. Gynaecol. East Central Afr. 1: 148 (1982).Google Scholar